Nectar Lifesciences Ltd. Share Price

Overview

Nectar Lifesciences Ltd. share price is currently ₹11.03, down by - ₹0.62 (5.32%) from its previous closing price of ₹11.65. The share price has declined -0.81% over the past month and declined -24.3% over the past year. The stock's 52-week low and high are ₹9.09 and ₹22.06, respectively. Nectar Lifesciences Ltd. has a market capitalisation of ₹ 240.00 Cr. The share price was last updated on 11 Sep 2026, 03:54 PM IST.

Nectar Lifesciences Ltd.
Nectar Lifesciences Ltd.
NECLIFE
 0.00
- 0.62
5.32%
Healthcare
 0.00(%)1D

Updated: 11 Sep 2026, 03:54:35 pm IST

Market Data

Open Price

 11.46

Prev. Close

 11.65
 10.94

Day Low

 11.71

Day High

 9.09

52 Week Low

 22.06

52 Week High

HealthcarePharmaceuticals & Drugs
CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

-0.96

Sector PE

44.30

PB Ratio

0.37

Sector PB

5.94

EPS

-11.50

Dividend Yield

0.00

Today's Volume

110.889 K

5 Day Avg. Volume

161.693 K

PEG Ratio

0.00

Market Cap.

₹ 240.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Corporate Actions will be available shortly.

Mutual Fund Ownership

Mutual Fund Holder
Jul 26
Shares held
Aug 26
Shares held
Motilal Oswal BSE Healthcare ETF2.55 k
2.56 k
(0.16%)
Bandhan BSE Healthcare Index Fund - Regular Plan - Growth1.37 k
1.20 k
(12.33%)

About Nectar Lifesciences Ltd. 👋

Nectar Lifesciences Limited is an India-based pharmaceutical company. The Company's business areas include active pharmaceutical ingredients (APIs) and intermediates, formulations/finished dosage formulations (FDF), menthol and mint derivatives, and empty hard gelatin capsules. The Company is engaged in the manufacturing of oral and sterile cephalosporin products. Its oral cephalosporins include cefixime, cefurozime axetil crystalline, cefuroxime axetil amorphous, cedpodoxime proxetil, cefprozil and cefdinir. Its sterile cephalosporins include cefotaxime sodium, ceftriaxone sodium, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate and cefepime arginine. Its capacities include cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium and ceftriaxone sodium. The Company offers contract manufacturing capabilities for solid dosage forms, such as tablets, capsules, dry powder oral suspension and granules and injectable for cephalosporins.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Dhwani Patel

Dhwani Patel

16 May • 10:52 PM · SEBI-Registered Analyst

ECLERX
Bearish trend continuation

eClerx Services has slipped into a strong bearish trend after failing to sustain higher levels near recent swing highs. The sharp breakdown and consistent lower highs reflect persistent selling pressure, with momentum clearly favoring the bears in the near term. Until the stock starts reclaiming key resistance zones, rallies may continue to face supply-driven weakness.

ECLERX

See More
Sunil Kotak

Sunil Kotak

15 Mar • 7:42 AM · SEBI-Registered Analyst

Stock in News to keep on radar

Stocks to Watch

JKLAKSHMI
The company has been declared the ‘preferred bidder’ for the mining lease of the Juipahar New Umrangso Limestone Block (A and B) in Assam. The limestone blocks (A and B) are spread over an area of 405 hectares. Additionally, the board has approved the acquisition of a 77.96 percent equity shareholding in NECEM Cements. Max Financial Services The board has approved fund-raising worth Rs 2,000 crore via a qualified institutional placement (QIP) or any other method. The proposed utilisation of the funds is primarily to meet the funding requirements of its material subsidiary, Axis Max Life Insurance, to support its business growth and expansion plans, with the balance to be used for general corporate purposes. Manorama Industries -
MANORAMA
The board has approved raising funds of up to Rs 500 crore through the issuance of equity shares, non-convertible debt instruments along with warrants or other convertible securities, via a qualified institutional placement or any other method. Nectar Lifesciences -
NECLIFE
The company has entered into an inter-corporate loan agreement worth up to Rs 100 crore with Avensis Exports. Avensis Exports is a subsidiary of the company. Balaji Amines -
BALAMINES
Balaji Amines is currently experiencing significant logistics disruptions in the procurement of ammonia, one of the key raw materials used in the manufacture of methylamines, ethylamines, and their derivatives, due to the ongoing war in the Middle East region. The situation has arisen due to the non-availability of ammonia. The disruption has adversely affected the supply of Liquefied Natural Gas (LNG)—a key input used for the production of ammonia by most fertiliser manufacturers in India. Consequently, several ammonia manufacturers have expressed their inability to supply the product during this period due to force majeure conditions. All this is for information only. This is not a buy/sell recommendation. Thank you, Technofunda24

See More
Akshay Patel

Akshay Patel

3 Mar • 11:41 AM · SEBI-Registered Analyst

NECLIFE
board approved an inter-corporate loan of up to INR 120 crores to wholly owned subsidiary Avensis Exports Private Limited during their March 02, 2026 meeting. The loan will be provided after acquisition completion, with detailed regulatory disclosures to follow upon finalization of the definitive agreement. The company acknowledged an administrative oversight in initial disclosure timing while reaffirming commitment to regulatory compliance. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.

See More
Akshay Patel

Akshay Patel

12 Nov • 8:07 AM · SEBI-Registered Analyst

NECLIFE
has finalized the slump sale of its active pharmaceutical ingredients (API) and formulations business to Cephi Lifesciences Private Limited on November 10, 2025. The transaction included an asset sale and was executed following agreements signed on July 07, 2025. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.

See More

News & Events

Frequently Asked Questions

What is the share price of Nectar Lifesciences Ltd.?

What is the market cap of Nectar Lifesciences Ltd.?

Should I buy Nectar Lifesciences Ltd. stock now?

What is the 52 week high and low of Nectar Lifesciences Ltd.?

Is the Nectar Lifesciences Ltd. stock good to buy?

Is Nectar Lifesciences Ltd. a good buy for the long term?

Is Nectar Lifesciences Ltd. overvalued or undervalued?

What is the PE and PB ratio of Nectar Lifesciences Ltd.?

Start Now